Efficacy, safety, and immunogenicity of rurioctocog alfa pegol for prophylactic treatment in previously treated patients with severe hemophilia A: a systematic review and meta-analysis of clinical trials

Background: Patients with severe hemophilia often present with painful joint and soft tissue bleeding which may restrict them from their daily activities. The current standard of care still relies on a regular prophylactic factor VIII (FVIII), which has a high daily treatment burden. Recently, rurio...

Descripción completa

Detalles Bibliográficos
Autores principales: Witarto, Bendix Samarta, Visuddho, Visuddho, Witarto, Andro Pramana, Sutanto, Henry, Wiratama, Bayu Satria, Wungu, Citrawati Dyah Kencono
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2022
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8787562/
https://www.ncbi.nlm.nih.gov/pubmed/35136579
http://dx.doi.org/10.12688/f1000research.73884.3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8787562/
https://www.ncbi.nlm.nih.gov/pubmed/35136579
http://dx.doi.org/10.12688/f1000research.73884.3

Ejemplares similares